CN103611093B - A kind of Chinese medicine composition for the treatment of pulmonary carcinoma - Google Patents
A kind of Chinese medicine composition for the treatment of pulmonary carcinoma Download PDFInfo
- Publication number
- CN103611093B CN103611093B CN201310669278.3A CN201310669278A CN103611093B CN 103611093 B CN103611093 B CN 103611093B CN 201310669278 A CN201310669278 A CN 201310669278A CN 103611093 B CN103611093 B CN 103611093B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for the treatment of pulmonary carcinoma, it can improve patients ' life quality and survival rate.Crude drug of the present invention is made up of following component: Radix Eriobotryae, Rhizoma Imperatae, Exocarpium Citri Grandis, Semen Armeniacae Amarum, Semen Caryae Cathayensis, Radix Adenophorae, Radix Glehniae, Radix Pseudostellariae, Radix Scrophulariae, Radix Ophiopogonis, Semen Litchi, Rhizoma Sparganii, Rhizoma Curcumae, Fructus Ligustri Lucidi, Bulbus Fritillariae Uninbracteatae, the Radix Astragali, Radix Sophorae Tonkinensis, Squama Manis, Radix Scutellariae, Cornu Bubali, Radix Platycodonis, Rhizoma Polygonati, Radix Notoginseng, Ganoderma, Radix Achyranthis Bidentatae, Herba Selaginellae Doederleinii, asparagus, Fructus Schisandrae Chinensis, Herba Hedyotidis Diffusae, Herba Houttuyniae.The present invention is made up of the multiple Chinese herbal medicine with anticancer function, compares have the little feature of toxic and side effects with general chemicals, and its anticancer effect is obvious, effectively can reduce the incidence rate of complication for patients, thus improves the cure rate of patients with lung cancer.
Description
Technical field
The invention belongs to Chinese medicine composition, be specifically related to a kind of Chinese medicine composition of the treatment pulmonary carcinoma be made up of the multiple Chinese herbal medicine with anticancer function.
Background technology
Pulmonary carcinoma is a kind of disease, it is characterized by paracytic uncontrolled growth, and is spread to other position by original site, this diffusion is as uncontrollable, by infringement critical organ and then cause exhaustion, finally cause death, become one of maximum public health problem in the whole world.Patients with lung cancer generally adopts the therapeutic alliance of operation, chemotherapy, radiotherapy, wherein chemotherapy is unique whole body therapeutic means, the postoperative important measures preventing diffusion, prevention of recurrence, also be the most effective Therapeutic Method that the Patients with Advanced Lung Cancer losing operative treatment chance can be selected, therefore chemotherapy has nuclear status in antineoplaston, and has whole process.The curative effect of chemotherapy is affirmative, but chemotherapeutics belongs to cytotoxic drug, has certain toxicity.Be mainly manifested in three aspects: be first all presumable side effect of most of chemotherapeutics, such as leukocyte decline, vomiting and alopecia etc., the place that these side effect occur the mainly growth fraction such as bone marrow, gastrointestinal mucosa and hair follicle is organized faster, these side effect will soon occur when chemotherapy, although can comparatively fast recover after stopping chemotherapy, some patients is because tolerating adjustment dosage even abandoning cure of having to; Next is the side effect that individual drugs causes specific system, and such as anthracene nucleus medicament can cause cardiac toxicity, and bleomycin can affect respiratory system etc. will cause clinical unexpected generation; 3rd is side effect at a specified future date, commonly on the fertility impact of system and secondary carcinogenic.The side effect caused is serious and obviously, these untoward reaction limit its clinical practice and curative effect.
Chinese Traditional Medicine has the applicating history of thousands of years, for huge contribution has been made in the procreation health care of the Chinese nation.Its primary treatment medicament sources is in natural drug, and due to determined curative effect, untoward reaction is slight, is progressively familiar with just in the world and accepts.TCM Oncology has driven the development of the basic and clinic studies of Chinese medicine medicine for preventing as independently clinical speciality, from clinical practice situation, Chinese traditional treatment has obvious effect to the modern antineoplaston effect of raising, mitigation symptoms and the aspect such as raising patients ' life quality and prolongation time-to-live.
Summary of the invention
The object of the invention is the defect existed to overcome prior art, for the deficiency that existing clinical antineoplastic is treated, thering is provided a kind of take Chinese crude drug as the medicine of the treatment pulmonary carcinoma of waste, and its curative effect is high, symptom alleviates obviously, can improve patients ' life quality and extend the time-to-live.
In order to realize object of the present invention, the present invention adopts following scheme:
Treat a Chinese medicine composition for pulmonary carcinoma, the crude drug of its Chinese medicine is made up of the component of following weight parts proportioning:
Radix Eriobotryae 40 ~ 70 parts, Rhizoma Imperatae 30 ~ 45 parts, Exocarpium Citri Grandis 50 ~ 60 parts, Semen Armeniacae Amarum 150 ~ 180 parts, Semen Caryae Cathayensis 22 ~ 25 parts, Radix Adenophorae 40 ~ 44 parts, Radix Glehniae 40 ~ 44 parts, Radix Pseudostellariae 40 ~ 44 parts, Radix Scrophulariae 40 ~ 44 parts, Radix Ophiopogonis 38 ~ 42 parts, Semen Litchi 30 ~ 35 parts, Rhizoma Sparganii 35 ~ 40 parts, Rhizoma Curcumae 35 ~ 40 parts, Fructus Ligustri Lucidi 50 ~ 65 parts, Bulbus Fritillariae Uninbracteatae 50 ~ 65 parts, the Radix Astragali 160 ~ 180 parts, Radix Sophorae Tonkinensis 70 ~ 90 parts, Squama Manis 65 ~ 70 parts, Radix Scutellariae 47 ~ 50 parts, Cornu Bubali 30 ~ 34 parts, Radix Platycodonis 60 ~ 65 parts, Rhizoma Polygonati 70 ~ 80 parts, Radix Notoginseng 35 ~ 42 parts, Ganoderma 40 ~ 45 parts, Radix Achyranthis Bidentatae 28 ~ 32 parts, Herba Selaginellae Doederleinii 28 ~ 32 parts, asparagus 90 ~ 100 parts, Fructus Schisandrae Chinensis 30 ~ 33 parts, Herba Hedyotidis Diffusae 40 ~ 45 parts, Herba Houttuyniae 36 ~ 42 parts.
Wherein in some embodiments, the crude drug of described Chinese medicine is made up of the component of following weight parts proportioning:
Radix Eriobotryae 50 parts, Rhizoma Imperatae 30 parts, Exocarpium Citri Grandis 60 parts, Semen Armeniacae Amarum 160 parts, Semen Caryae Cathayensis 22 parts, Radix Adenophorae 44 parts, Radix Glehniae 44 parts, Radix Pseudostellariae 44 parts, Radix Scrophulariae 44 parts, Radix Ophiopogonis 38 parts, Semen Litchi 30 parts, Rhizoma Sparganii 38 parts, Rhizoma Curcumae 38 parts, Fructus Ligustri Lucidi 55 parts, Bulbus Fritillariae Uninbracteatae 55 parts, the Radix Astragali 180 parts, Radix Sophorae Tonkinensis 80 parts, Squama Manis 66 parts, Radix Scutellariae 49 parts, Cornu Bubali 30 parts, Radix Platycodonis 60 parts, Rhizoma Polygonati 80 parts, Radix Notoginseng 40 parts, Ganoderma 45 parts, Radix Achyranthis Bidentatae 30 parts, Herba Selaginellae Doederleinii 30 parts, asparagus 100 parts, Fructus Schisandrae Chinensis 30 parts, Herba Hedyotidis Diffusae 40 parts, Herba Houttuyniae 41 parts.
Radix Eriobotryae: bitter is flat;
Cure mainly: preventing phlegm from forming and stopping coughing, depressed liver-energy dispersing and QI regulating.Control cough, hernia, edema, scrofula.
Rhizoma Imperatae: sweet in the mouth, cold;
Cure mainly: cooling blood for hemostasis, heat-clearing and toxic substances removing.For spitting blood, hematuria, pyretic stranguria, edema, jaundice, dysuria, calentura excessive thirst, gastric heat is vomitted the sound of vomiting, coughs.
Exocarpium Citri Grandis: nature and flavor are bitter, pungent, warm;
Cure mainly: reduce phlegm, regulating qi-flowing for strengthening spleen, to help digestion, control expectorant in the heart stagnant, cough and asthma, vomiting singultus, eating accumulation.
Semen Armeniacae Amarum: bitter in the mouth;
Cure mainly: expelling phlegm for arresting cough, intestine moistening.
Semen Caryae Cathayensis: sweet in the mouth, gas is fragrant;
Cure mainly: lung moistening QI invigorating, nourish blood relieving asthma, moistening the lung and resolving the phlegm goes all effects of deficiency and coldness.
Radix Adenophorae: sweet light, property is put down;
Cure mainly: the gas of tonifying the lung spleen, is applicable to deficiency of both the splenic and pulmonary QI, clearing away heat and nourishing YIN, nourishing the lung to arrest cough cures mainly tracheitis, pertussis, cough due to lung-heat, coughs up phlegm yellow thick, light red tongue, arteries and veins weak person.
Radix Glehniae: Gan Han;
Cure mainly: kind the moon of supporting lung stomach, be applicable to calentura later stage or prolonged illness yin asthenia generating intrinsic heat, dry cough, expectorant is few, low grade fever, xerostomia, red tongue, and tongue is few, thready pulse weak person.
Radix Pseudostellariae: sweet, micro-hardship is flat;
Cure mainly: the disease such as insufficiency of the spleen lack of appetite, fatigue and weakness, cardiopalmus spontaneous perspiration, cough due to deficiency of the lung, thirst due to body fluid deficiency.
Radix Scrophulariae: sweet in the mouth, hardship, salty;
Cure mainly: the diseases such as consumption of body fluid caused by febrile disease, excessive thirst constipation, laryngopharynx swelling and pain, scrofula, maculae caused by violent heat pathogen.
Radix Ophiopogonis: sweet, micro-hardship;
Cure mainly: Yin-nourishing and body fluid promoting, nourishing the lung to arrest cough, clear away heart-fire relieving restlessness.
Semen Litchi: acrid in the mouth is bitter;
Cure mainly: promoting QI to circulate and dispersing the agglomeration of the pathogens, cold-dispelling pain-relieving.
Rhizoma Sparganii: acrid in the mouth is puckery, cool;
Cure mainly: control lump in the abdomen, gather, distending pain over the hypochondrium, food stagnation distending pain, dysmenorrhea.
Rhizoma Curcumae: mildly bitter flavor, feeble QI is fragrant;
Cure mainly: coagulation of QI-blood, trusted subordinate's distending pain, lump in the abdomen, gathers, and dyspepsia does not disappear, traumatic injury.
Fructus Ligustri Lucidi: odorless, sweet in the mouth, micro-bitterness;
Cure mainly: poor vision, visual deterioration, early whitening of beard and hair, soreness of waist tinnitus and fever due to yin deficiency etc.
Bulbus Fritillariae Uninbracteatae: bitter, sweet, is slightly cold;
Cure mainly: relieving cough and resolving phlegm, heat clearing away eliminating stagnation.
The Radix Astragali: slightly warm in nature, sweet in the mouth.
Cure mainly: deficient qi and blood, spontaneous perspiration, chronic diarrhea proctoptosis, uterine prolapse, nephritis edema, albuminuria, diabetes, chronic ulcer.
Radix Sophorae Tonkinensis: bitter, cold;
Cure mainly: control retropharyngeal abscess, acute throat trouble, sore throat, gingival swelling and pain, dyspnea with fullness of the chest heat syndrome cough, jaundice, dysentery.
Squama Manis: cold nature, salty in the mouth.
Cure mainly: blood circulation promoting and dispersing pathogen accumulation, stimulating milk secretion of stimulating the menstrual flow, eliminating carbuncle are burst hard.Main blood stasis amenorrhea, lump in the abdomen, rheumatic arthralgia, agalactia, carbuncle, scrofula.
Radix Scutellariae: bitter in the mouth, cold in nature;
Cure mainly: heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive.
Cornu Bubali: bitter salty, cold;
Cure mainly: heat clearing away, removing heat from blood, arresting convulsion, removing toxic substances.
Radix Platycodonis: bitter in the mouth, pungent, slightly warm in nature;
Cure mainly: eliminating phlegm and stopping cough, lung qi dispersing, evacuation of pus.
Rhizoma Polygonati: sweet is flat;
Cure mainly: weakness of the spleen and stomach, fatigue and asthenia, xerostomia lack of appetite, deficiency of the lung cough caused by dryness, asthenia of essence and blood, interior-heat such as to be quenched one's thirst the disease.
Radix Notoginseng: sweet in the mouth, micro-hardship, warm in nature;
Cure mainly: fall and flutter congestive edema, thoracic obstruction angor, lump in the abdomen; Blood stasis amenorrhea; Dysmenorrhea; Puerperal, stasis of blood the moon was suffered from abdominal pain; Sore, carbuncle and painful swelling.
Ganoderma: property is put down, bitter in the mouth;
Cure mainly: asthenia, cough, asthma, insomnia, dyspepsia, malignant tumor etc.
Radix Achyranthis Bidentatae: property is put down, bitter in the mouth, acid.
Cure mainly: invigorating the liver and kidney, bone and muscle strengthening, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards., amenorrhea lump in the abdomen, dizziness due to hyperactivity of liver-YANG unable for soreness of waist and knee joint, muscles and bones.
Herba Selaginellae Doederleinii: sweet in the mouth, micro-hardship, puckery, cool in nature;
Cure mainly: heat-clearing and toxic substances removing, expelling wind and removing dampness, hemostasis, the effect such as anticancer.
Asparagus: asparagus and Germinatus Phragmitis is cool, sweet, bitter;
Cure mainly: lung moistening antitussive, eliminate the phlegm parasite killing.
Fructus Schisandrae Chinensis: warm, sour, sweet;
Cure mainly: astringe the lung, nourishing kidney, promote the production of body fluid, receive antiperspirant, arresting seminal emission.
Herba Hedyotidis Diffusae: bitter, light, cold in nature;
Cure mainly: heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness.
Herba Houttuyniae: cold nature, bitter in the mouth;
Cure mainly: the main lung abscess vomiting pus of pyretic stranguria; Expectorant dyspnea of heat type is coughed; Hematodiarrhoea; Carbuncle sore tumefacting virus; Pyretic stranguria.
Wherein in some embodiments, described Chinese medicine composition can be prepared as a kind of pharmaceutically acceptable preparation (carrier or excipient) through extracting, mixing; The preparation of described Chinese medicine composition, it is above-mentioned Chinese medicine composition and other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
Wherein in some embodiments, the mixture of effective ingredient after extracting of described Chinese medicine composition, can be prepared as a kind of pharmaceutically acceptable preparation (carrier or excipient); The preparation of described Chinese medicine composition, it is the extract of above-mentioned Chinese medicine composition and other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, soft capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
A kind of medicine for the treatment of pulmonary carcinoma of the present invention, by the multiple Chinese herbal medicine with anticancer function, through with other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, be mainly used in the treatment of pulmonary carcinoma, there is rapid-action, good effect, the features such as taking convenience, and there is the little feature of toxic and side effects compared with general chemicals.Its anticancer effect, except showing effective anticancer, the immunity of patient can also be strengthened, improve hemorheology index, change oncogene expression, cancer cell specific induction of apoptosis, anticancer is bred, and can reduce patient's injury that normal structure is subject to when accepting the treatment means such as chemotherapy, radiotherapy, reduces the incidence rate of complication for patients, thus improve the cure rate of patients with lung cancer, reduce the mortality rate of pulmonary carcinoma.
Detailed description of the invention
For feature of the present invention, technological means and the specific purposes reached, function can be understood further, below in conjunction with detailed description of the invention, the present invention is described in further detail.
The Chinese medicine composition dosage with obvious antitumor action provided by the invention suitably can adjust according to changes such as the orders of severity of route of administration, patient individual difference, clinical application and disease, and the crude drug of Chinese medicine is made up of the component of following weight parts proportioning:
Radix Eriobotryae 50 parts, Rhizoma Imperatae 30 parts, Exocarpium Citri Grandis 60 parts, Semen Armeniacae Amarum 160 parts, Semen Caryae Cathayensis 22 parts, Radix Adenophorae 44 parts, Radix Glehniae 44 parts, Radix Pseudostellariae 44 parts, Radix Scrophulariae 44 parts, Radix Ophiopogonis 38 parts, Semen Litchi 30 parts, Rhizoma Sparganii 38 parts, Rhizoma Curcumae 38 parts, Fructus Ligustri Lucidi 55 parts, Bulbus Fritillariae Uninbracteatae 55 parts, the Radix Astragali 180 parts, Radix Sophorae Tonkinensis 80 parts, Squama Manis 66 parts, Radix Scutellariae 49 parts, Cornu Bubali 30 parts, Radix Platycodonis 60 parts, Rhizoma Polygonati 80 parts, Radix Notoginseng 40 parts, Ganoderma 45 parts, Radix Achyranthis Bidentatae 30 parts, Herba Selaginellae Doederleinii 30 parts, asparagus 100 parts, Fructus Schisandrae Chinensis 30 parts, Herba Hedyotidis Diffusae 40 parts, Herba Houttuyniae 41 parts.Its every daily dose counts 5g ~ 50g by crude drug, and preferably every daily dose is 15g ~ 30g, can once or several times use
Crude drug is mixed with by Chinese crude drug or its extract obtains through pulverizing extraction, and obtained pharmaceutical preparation is tablet, capsule, granule, pill etc.
Instructions about how to take medicine: warm water takes.One day 3 times, one time 6, a 0.3g ~ 1g, observed by the long-term follow of out-patient 15 example, transference cure, the no longer medication of 12 examples, cure rate is up to 80%.
Successful case:
Patient Lee's ×× (man) did the inspection such as routine blood test, biochemical routine in January, 2013, and lung tumor antigen related assays, wherein CA15-3:40.41 U/mL in lung tumor antigen related assays, CEA:188.1 ng/mL severe overweight.
2013-01-11 Chest Image CT reports: patient's superior lobe of right lung soft tissue agglomerate shadow, and greatest cross-section is 48 × 33mm about, and focus and upper right hilus pulumonis are demarcated unclear, the lesser tubercle soft-tissue density shadow of blade tip Duan Yijian mono-size about 13 × 11mm on its adjacent rear.Companion's perilesional is scorching, lymphangitis carcinomatosa, the multiple lymphatic metastasis of mediastinum.
2013-01-16 breast, upper abdomen CT be unenhanced+strengthen audit report: and a swollen thing is shown in by superior lobe of right lung, and size is 49 × 59mm about, and perilesional is shown in multiple patch shape, and class nodositas focus, the maximum is 13 × 17mm about, obscure boundary.Bilateral supraclavicular fossa, mediastinum, the multiple lymph node of right lung door, the maximum is 11 × 16mm about.The multiple focus of thyroid bilobate, the maximum is 10 × 6mm about.Calculus in liver S7 bile duct.
2013-01-16 thoracic ultrasound is reported: supraclavicular region, right side can be visited and multiple lymph node, more about 14 × 13mm, and border is clear, circular, and lymph door disappears.
Patient is from February, 2013, and after taking medicine three months, sb.'s illness took a favorable turn, foci disappearance, does not need to have taken medicine, returns to one's perfect health.
Patient Sun Xiansheng in JIUYUE, 2011, patient is because of cough, expectoration, and apoplexy due to phlegm is admission examination with blood.When having a medical check-up, CT finds right upper lung solitary nodule, and size is 2.0 × 2.0cm, considers that pulmonary carcinoma probability is large.
Because can not clear and definite whether be pulmonary carcinoma, therefore be again PET/CT check.PET/CT finding: the dense poly-stove of right upper lung nodositas radioactivity, intralesional increased radioactivity is even, and clear border, SUV is 2.8.
PET/CT diagnoses: right upper lung nodositas hypermetabolism stove, is thought of as pulmonary carcinoma.
Pathological diagnosis: lung squamous cancer (being more common in central type carcinoma of lung).
Patient consumes is after four months, and focus controls, and does not breathe heavily and does not cough, and can return company's working, does not need to take that other is medicinal, drug withdrawal.
The above embodiment only have expressed several embodiment of the present invention, and it describes comparatively concrete and detailed, but therefore can not be interpreted as the restriction to the scope of the claims of the present invention.It should be pointed out that for the person of ordinary skill of the art, without departing from the inventive concept of the premise, can also make some distortion and improvement, these all belong to protection scope of the present invention.Therefore, the protection domain of patent of the present invention should be as the criterion with claims.
Claims (4)
1. treat a Chinese medicine composition for pulmonary carcinoma, it is characterized in that, the crude drug of its Chinese medicine is made up of the component of following weight parts proportioning:
Radix Eriobotryae 40 ~ 70 parts, Rhizoma Imperatae 30 ~ 45 parts, Exocarpium Citri Grandis 50 ~ 60 parts, Semen Armeniacae Amarum 150 ~ 180 parts, Semen Caryae Cathayensis 22 ~ 25 parts, Radix Adenophorae 40 ~ 44 parts, Radix Glehniae 40 ~ 44 parts, Radix Pseudostellariae 40 ~ 44 parts, Radix Scrophulariae 40 ~ 44 parts, Radix Ophiopogonis 38 ~ 42 parts, Semen Litchi 30 ~ 35 parts, Rhizoma Sparganii 35 ~ 40 parts, Rhizoma Curcumae 35 ~ 40 parts, Fructus Ligustri Lucidi 50 ~ 65 parts, Bulbus Fritillariae Uninbracteatae 50 ~ 65 parts, the Radix Astragali 160 ~ 180 parts, Radix Sophorae Tonkinensis 70 ~ 90 parts, Squama Manis 65 ~ 70 parts, Radix Scutellariae 47 ~ 50 parts, Cornu Bubali 30 ~ 34 parts, Radix Platycodonis 60 ~ 65 parts, Rhizoma Polygonati 70 ~ 80 parts, Radix Notoginseng 35 ~ 42 parts, Ganoderma 40 ~ 45 parts, Radix Achyranthis Bidentatae 28 ~ 32 parts, Herba Selaginellae Doederleinii 28 ~ 32 parts, asparagus 90 ~ 100 parts, Fructus Schisandrae Chinensis 30 ~ 33 parts, Herba Hedyotidis Diffusae 40 ~ 45 parts, Herba Houttuyniae 36 ~ 42 parts.
2. a kind of Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, is characterized in that, the crude drug of described Chinese medicine is made up of the component of following weight parts proportioning:
Radix Eriobotryae 50 parts, Rhizoma Imperatae 30 parts, Exocarpium Citri Grandis 60 parts, Semen Armeniacae Amarum 160 parts, Semen Caryae Cathayensis 22 parts, Radix Adenophorae 44 parts, Radix Glehniae 44 parts, Radix Pseudostellariae 44 parts, Radix Scrophulariae 44 parts, Radix Ophiopogonis 38 parts, Semen Litchi 30 parts, Rhizoma Sparganii 38 parts, Rhizoma Curcumae 38 parts, Fructus Ligustri Lucidi 55 parts, Bulbus Fritillariae Uninbracteatae 55 parts, the Radix Astragali 180 parts, Radix Sophorae Tonkinensis 80 parts, Squama Manis 66 parts, Radix Scutellariae 49 parts, Cornu Bubali 30 parts, Radix Platycodonis 60 parts, Rhizoma Polygonati 80 parts, Radix Notoginseng 40 parts, Ganoderma 45 parts, Radix Achyranthis Bidentatae 30 parts, Herba Selaginellae Doederleinii 30 parts, asparagus 100 parts, Fructus Schisandrae Chinensis 30 parts, Herba Hedyotidis Diffusae 40 parts, Herba Houttuyniae 41 parts.
3. a kind of Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, is characterized in that, described Chinese medicine composition is through extracting, being mixed with as the pharmaceutically acceptable preparation of one; The preparation of described Chinese medicine composition, it is above-mentioned Chinese medicine composition and other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
4. a kind of Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, is characterized in that, the mixture of effective ingredient after extracting of described Chinese medicine composition, is prepared as a kind of pharmaceutically acceptable preparation; The preparation of described Chinese medicine composition, it is the extract of above-mentioned Chinese medicine composition and other pharmaceutically pharmaceutical preparation of being formed of acceptable pharmaceutical carrier or mixed with excipients, and its dosage form is said following dosage form on pharmaceutics: comprise tablet, capsule, granule, pill, powder, unguentum, suspensoid, oral liquid, injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310669278.3A CN103611093B (en) | 2013-12-11 | 2013-12-11 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310669278.3A CN103611093B (en) | 2013-12-11 | 2013-12-11 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103611093A CN103611093A (en) | 2014-03-05 |
| CN103611093B true CN103611093B (en) | 2015-10-28 |
Family
ID=50161826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310669278.3A Active CN103611093B (en) | 2013-12-11 | 2013-12-11 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103611093B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524374A (en) * | 2014-12-30 | 2015-04-22 | 潘振奎 | Traditional Chinese medicine formula for treating lung cancer and preparation method of traditional Chinese medicine formula |
| CN107789478A (en) * | 2017-12-21 | 2018-03-13 | 曹国荣 | Eliminate pharmaceutical composition of cancer patient's deficiency of Yin accumulation stool and preparation method thereof |
| CN111329949A (en) * | 2020-03-05 | 2020-06-26 | 周口师范学院 | Medicine composition for treating lung cancer |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241438A (en) * | 1999-06-23 | 2000-01-19 | 陈大明 | Lung cancer treating Chinese medicine preparation and its preparation |
| CN101049484A (en) * | 2007-05-14 | 2007-10-10 | 郝来勤 | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers |
| CN101584801A (en) * | 2008-05-19 | 2009-11-25 | 尚爱永 | Traditional Chinese medicine for treating primary lung cancer |
| CN102949679A (en) * | 2012-12-04 | 2013-03-06 | 周玉娟 | Medicine for curing lung cancer and preparation method thereof |
-
2013
- 2013-12-11 CN CN201310669278.3A patent/CN103611093B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241438A (en) * | 1999-06-23 | 2000-01-19 | 陈大明 | Lung cancer treating Chinese medicine preparation and its preparation |
| CN1092523C (en) * | 1999-06-23 | 2002-10-16 | 陈大明 | Lung cancer treating Chinese medicine preparation and its preparation |
| CN101049484A (en) * | 2007-05-14 | 2007-10-10 | 郝来勤 | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers |
| CN101584801A (en) * | 2008-05-19 | 2009-11-25 | 尚爱永 | Traditional Chinese medicine for treating primary lung cancer |
| CN102949679A (en) * | 2012-12-04 | 2013-03-06 | 周玉娟 | Medicine for curing lung cancer and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| "肿瘤科金方11 肺癌";收藏人：传播中医馆;《360doc个人图书馆http://www.360doc.com/content/13/0314/14/18452_271464797.shtml》;20130314;1-16 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103611093A (en) | 2014-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102847064A (en) | Chinese herbal medicine used for inhibition of malignant tumor metastasis | |
| CN103611093B (en) | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma | |
| CN103463554B (en) | A kind of treat malignant tumor pharmaceutical composition and preparation method and purposes | |
| CN101569738B (en) | Plaster for treating mastitis, hyperplasia of mammary glands, breast lumps, hydrarthrosis, traumatic injury, preparation method and application thereof | |
| CN103721196A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN105233188A (en) | Traditional Chinese medicine composition for treating liver cancer and application of traditional Chinese medicine composition | |
| CN104800510A (en) | Traditional Chinese medicine composition for treating stomach cancer | |
| CN104784508B (en) | For improving the preparation method of the Chinese medicine preparation of malignant tumor patient immunologic function | |
| CN105770691A (en) | Medicinal preparation for treating cervical cancer and application thereof | |
| CN104623450A (en) | Traditional Chinese medicine preparation for treating breast cancer | |
| CN104784509B (en) | For improving the Chinese medicine preparation of malignant tumor patient immunologic function | |
| CN103877397B (en) | A kind of medicine of radiotherapy injury of lung and preparation method | |
| CN103989994A (en) | Pharmaceutical preparation for treating chronic urticaria | |
| CN103127398B (en) | Chinese medicament for treating cancers and preparation method thereof | |
| CN103520653B (en) | Traditional Chinese medicine composition for treating gastric cancer | |
| CN102000263B (en) | Traditional Chinese medicine preparation for treating lung cancer | |
| CN105311468A (en) | Traditional Chinese medicine composition for treating lymph cancer and preparation method thereof | |
| CN105535626A (en) | Traditional Chinese medicine for treating tuberculosis by combination with anti-tuberculosis western medicine | |
| CN106266107A (en) | A kind of Chinese medicine composition treating sucutaneous nodule goiter and preparation method thereof | |
| CN106334140A (en) | Traditional Chinese medicine composition and preparation method thereof | |
| CN105194484A (en) | Chinese herb preparation for preventing and treating ovarian cancer and preparation method | |
| CN105456616A (en) | Traditional Chinese medicine formulation for treating pancreatic cancer and preparation method thereof | |
| CN102416059B (en) | Medicinal composition for treating colon cancer | |
| CN105106798A (en) | Traditional Chinese medicine composition for preventing and treating ovarian cancer and preparation method thereof | |
| CN104888105A (en) | Traditional Chinese medicine for treating primary liver cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| CB02 | Change of applicant information |
Address after: 523050 Guangdong province Dongguan City Wanjiang District Joint Village Second Industrial Zone No. 6 4 floor (Gary office building 4 floor) Dongguan Shenghong Biotechnology Co. Ltd. Applicant after: DONGGUAN DONGZHUO ZHONGTIAN BIOTECHNOLOGY CO., LTD. Address before: 523050 Guangdong province Dongguan City Wanjiang District Joint Village Second Industrial Zone No. 6 4 floor (Gary office building 4 floor) Dongguan Shenghong Biotechnology Co. Ltd. Applicant before: DONGGUAN SHENGHONG BIOTECHNOLOGY CO., LTD. |
|
| COR | Change of bibliographic data | ||
| GR01 | Patent grant |